[1]
“FEATURES OF THE PHARMACOEPIDEMIOLOGICAL DESCRIPTION OF POST-COVID-19 AHAB IN WOMEN”, the Conf. Hub, pp. 53–56, Aug. 2025, Accessed: Nov. 11, 2025. [Online]. Available: https://theconferencehub.com/index.php/tch/article/view/429